ChinaAMC CSI Biotechnology Thematic ETF (SHA:516500)
0.6570
0.00 (0.00%)
At close: Sep 22, 2026
SHA:516500 Holdings Information
SHA:516500 is an equity ETF with a total of 76 individual holdings.
Total Holdings
76
Top 10 Percentage
53.17%
Asset Class
Equity
ETF Category
Health Care
Assets
129.39M
PE Ratio
32.03
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SHA: 603259 | WuXi AppTec Co., Ltd. | 11.62% |
| 2 | SHA: 600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 10.16% |
| 3 | SHE: 300760 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 8.56% |
| 4 | SHE: 002821 | Asymchem Laboratories (Tianjin) Co., Ltd. | 3.82% |
| 5 | SHE: 300759 | Pharmaron Beijing Co., Ltd. | 3.55% |
| 6 | SHA: 688235 | BeOne Medicines AG | 3.49% |
| 7 | SHA: 600196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 3.37% |
| 8 | SHE: 300347 | Hangzhou Tigermed Consulting Co., Ltd | 2.96% |
| 9 | SHA: 688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 2.90% |
| 10 | SHA: 688331 | RemeGen Co., Ltd. | 2.73% |
| 11 | SHE: 000661 | Changchun High-Tech Industry (Group) Co., Ltd. | 2.58% |
| 12 | SHA: 688266 | Suzhou Zelgen Biopharmaceuticals Co., Ltd. | 2.56% |
| 13 | SHE: 300142 | Walvax Biotechnology Co., Ltd. | 2.47% |
| 14 | SHA: 603087 | Gan & Lee Pharmaceuticals. | 2.41% |
| 15 | SHE: 002252 | Shanghai RAAS Blood Products Co., Ltd. | 2.38% |
| 16 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 2.15% |
| 17 | n/a | Cash | 1.80% |
| 18 | SHE: 300122 | Chongqing Zhifei Biological Products Co., Ltd. | 1.66% |
| 19 | SHE: 002007 | Hualan Biological Engineering Inc. | 1.59% |
| 20 | SHA: 688114 | MGI Tech Co., Ltd. | 1.52% |
| 21 | SHA: 688319 | Chengdu Olymvax Biopharmaceuticals Inc. | 1.48% |
| 22 | SHA: 600161 | Beijing Tiantan Biological Products Co., Ltd. | 1.36% |
| 23 | SHE: 000534 | Wedge Industrial Co.,Ltd. | 1.33% |
| 24 | SHA: 688690 | Suzhou Nanomicro Technology Co., Ltd. | 1.27% |
| 25 | SHA: 603392 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | 1.22% |
As of Jun 30, 2026